New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
10:00 EDTCPA, BMO, SD, HAE, CHTR, PRU, UCBI, CLH, SIRI, COG, BPI, UNP, TFM, CCRN, GTAT, OCR, PLCM, QSII, SWY, SKUL, TEVA, BKE, IVNOn The Fly: Analyst Upgrade Summary
Copa Holdings (CPA) upgraded to Buy from Neutral at UBS... Cross Country Healthcare (CCRN) upgraded to Buy from Neutral at Citigroup... GT Advanced (GTAT) upgraded to Outperform from Neutral at Credit Suisse... Omnicare (OCR) upgraded to Buy from Neutral at UBS... Polycom (PLCM) upgraded to Buy from Neutral at Citigroup... Quality Systems (QSII) upgraded to Market Perform from Underperform at FBR Capital... Safeway (SWY) upgraded to Neutral from Sell at UBS... Skullcandy (SKUL) upgraded to Outperform from Market Perform at Northland Securities... Teva (TEVA) upgraded to Overweight from Equal Weight at Barclays... The Buckle (BKE) upgraded to Neutral from Sell at Janney Capital... The Fresh Market (TFM) upgraded to Buy from Neutral at UBS... Union Pacific (UNP) upgraded to Outperform from Market Perform at Avondale... Bridgepoint Education (BPI) upgraded to Outperform at William Blair... Bank of Montreal (BMO) upgraded to Sector Performer from Underperformer at CIBC... SandRidge Energy (SD) upgraded to Overweight at Stephens citing turnaround progress... Haemonetics (HAE) upgraded to Buy from Neutral at Sidoti... Charter (CHTR) upgraded at Northland Securities... Prudential (PRU) upgraded to Buy from Neutral at BofA/Merrill... United Community Banks (UCBI) upgraded to Buy from Hold at Sandler O'Neill... Sirius XM (SIRI) upgraded at Macquarie... Clean Harbors (CLH) upgraded at Raymond James... Cabot Oil & Gas (COG) upgraded to Buy from Accumulate at KLR Group... Ivanhoe Mines (IVN) upgraded to Buy from Neutral at UBS.
News For CPA;CCRN;GTAT;OCR;PLCM;QSII;SWY;SKUL;TEVA;BKE;TFM;UNP;BPI;BMO;SD;HAE;CHTR;PRU;UCBI;CLH;SIRI;COG;IVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 10, 2014
17:14 EDTGTATMarket ends week lower amid global growth worries
Subscribe for More Information
09:00 EDTGTATOn The Fly: Pre-market Movers
Subscribe for More Information
07:08 EDTGTATApple given at least 3 days to block info in GT bankruptcy case, Reuters says
Subscribe for More Information
October 9, 2014
18:47 EDTGTATOn The Fly: After Hours Movers
UP AFTER EARNINGS: Helen of Troy (HELE), up 3%... Barracuda Networks (CUDA), up marginally after reporting second quarter results. ALSO HIGHER: Sucampo Pharmaceuticals (SCMP), up 19.2% after announcing settlement agreement resolving patent litigation on AMITIZA... Civeo (CVEO), up 15% after Greenlight Capital reported a 9.99% stake in the company... EXCO Resources (XCO), up 10.6% after T. Boone Pickens says that company approached by buyers, reported by Bloomberg... EXACT Sciences (EXAS), up 3.7% after announcing final national coverage determination for Cologuard... US Ecology (ECOL), up 2.5% following announcement that it will replace Measurement Specialties (MEAS) in S&P 600. DOWN AFTER EARNINGS: Procera Networks (PKT), down 19.3%... Sizmek (SZMK), down 13.9% following third quarter revenue guidance... VOXX International (VOXX), down 12.5%... Knowles (KN), down 8.1% after lowering third quarter guidance... Microchip (MCHP), down 8.2% after lowering second quarter guidance... Juniper Networks (JNPR), down 3.6% after lowering third quarter outlook. ALSO LOWER: GT Advanced Technologies (GTAT), down 23.3% following a Bloomberg report that it will as to wind down sapphire operations.
18:32 EDTGTATGT Advanced to ask to wind down sapphire operations, Bloomberg reports
Subscribe for More Information
16:11 EDTTEVAAlexza reports 32,278 Adasuve units shipped to Teva in Q3
Subscribe for More Information
14:10 EDTSIRIShazam, Sun Broadcasting to launch customized, interactive radio content
Subscribe for More Information
12:46 EDTBPIDoE policy changes a negative for select Education stocks, says Deutsche Bank
Subscribe for More Information
12:37 EDTGTATGT Advanced argues to keep bankruptcy explanation documents sealed, Reuters says
GT Advanced argued on Thursday that it could not reveal the details of why it filed for bankruptcy, and that the court should keep the documents that explain why GT Advanced went bankrupt sealed, due to confidentiality agreements, Reuters reports. Reference Link
10:00 EDTBMOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Acuity Brands (AYI) upgraded at Oppenheimer... Agnico-Eagle (AEM) upgraded to Buy from Hold at Desjardins... Apple (AAPL) upgraded to Outperform from Perform at Oppenheimer... Bank of Montreal (BMO) upgraded to Buy from Hold at Canaccord... Basic Energy (BAS) upgraded to Hold from Underperform at Jefferies... BreitBurn Energy (BBEP) upgraded to Outperform from Perform at Oppenheimer... Golden Minerals (AUMN) upgraded at Roth Capital... Helmerich & Payne (HP) upgraded to Buy from Hold at Jefferies... II-VI (IIVI) upgraded to Buy from Neutral at DA Davidson... LivePerson (LPSN) upgraded at Credit Suisse... Luminex (LMNX) upgraded to Market Perform at Cowen... MGM Resorts (MGM) upgraded at Craig-Hallum... New Gold (NGD) upgraded to Buy from Hold at Desjardins... New Source Energy (NSLP) upgraded to Outperform from Perform at Oppenheimer... Pacific Coast Oil (ROYT) upgraded to Buy from Hold at Stifel... Pioneer Energy (PES) upgraded to Buy from Hold at Jefferies... Precision Drilling (PDS) upgraded to Strong Buy from Outperform at Raymond James... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Resource Capital (RSO) upgraded to Buy from Hold at MLV & Co.... Toyota (TM) upgraded to Buy from Neutral at BofA/Merrill... Transocean (RIG) upgraded to Outperform from Sector Perform at Iberia... Universal Technical (UTI) upgraded to Outperform from Market Perform at Wells Fargo... Vulcan Materials (VMC) upgraded to Buy from Neutral at Longbow.
09:41 EDTBKEBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
07:56 EDTBMOBank of Montreal upgraded to Buy from Hold at Canaccord
Subscribe for More Information
07:01 EDTBKEThe Buckle reports September SSS up 2.2%
Subscribe for More Information
October 8, 2014
15:25 EDTSWYNotable companies reporting after market close
Subscribe for More Information
13:41 EDTTFMThe Fresh Market backs FY14 adjusted EPS view $1.56-$1.66, consensus $1.57
Subscribe for More Information
11:45 EDTGTATApple 'surprised' by GT Advanced's Chapter 11 filing, WSJ reports
Apple (AAPL) says it was "surprised" by GT Advanced's (GTAT) Chapter 11 bankruptcy filing on Monday, the Wall Street Journal reports. Apple says it is focused on preserving jobs in Arizona and will continue to work with state and local officials "as we consider our next steps." GT Advanced is a partner for Apple's sapphire initiative. Reference Link
10:06 EDTUNPStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
08:05 EDTTEVATeva initiates NDA submission to FDA for CEP-33237
Teva Pharmaceutical announced the initiation of a rolling New Drug Application submission to the U.S. Food and Drug Administration for hydrocodone bitartrate extended-release tablets designed with Teva’s proprietary technology providing potential abuse-deterrent properties CEP-33237 as allowed for fast track designated products. Teva expects to complete the NDA submission by the end of 2014. Teva also announced positive results from a nasal Human Abuse Liability study which supports the NDA. The nasal HAL study found that in nondependent, recreational opioid users, abuse potential for crushed intranasal CEP-33237 was significantly lower than intranasal immediate-release hydrocodone. Teva has now completed positive HAL studies in the two most common routes of hydrocodone abuse, oral and intranasal. CEP-33237 demonstrated a safety profile in the Phase III study that is consistent with the known safety profile of hydrocodone and other opioid analgesic therapies. Adverse events reported in 5% or more of hydrocodone-treated patients during either the titration or double-blind treatment periods included nausea, constipation, vomiting, headache, somnolence and dizziness.
06:47 EDTTEVALawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link
05:45 EDTGTATStocks with implied volatility movement; GTAT SNSS
Stocks with implied volatility movement; GT Advanced (GTAT) 403, Sunesis (SNSS) 164 according to iVolatility.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use